EDS and Bleeding: Why Easy Bruising, Heavy Periods, and Platelet Dysfunction Matter

Easy bruising, heavy periods, frequent nosebleeds, gum bleeding, and prolonged bleeding after dental work are often treated as unrelated complaints.

In people with Ehlers-Danlos syndromes (EDS) or hypermobility spectrum disorders (HSD), however, these symptoms may be part of a broader bleeding tendency that deserves clinical attention. Research increasingly points to a multifactorial cause: fragile connective tissue, vulnerable small blood vessels, and, in some patients, altered platelet function.

EDS is a group of heritable connective-tissue disorders associated with joint hypermobility, skin findings, and varying degrees of tissue fragility. Bleeding has historically been attributed mainly to fragile blood vessels and reduced structural support around those vessels. Newer research suggests that this explanation may be incomplete: in at least some people with EDS, platelet signaling and function may also be impaired. The most accurate model is therefore multifactorial. Fragile connective tissue, vulnerable small vessels, and altered platelet responses may overlap in a single patient.

Why Does Ehlers-Danlos Syndrome Cause Easy Bruising and Bleeding?

Stopping bleeding requires more than a normal platelet count. After a blood vessel is injured, the vessel constricts, platelets adhere to exposed proteins such as collagen, platelets activate and aggregate into a temporary plug, and the coagulation system reinforces that plug with fibrin. This coordinated process is called hemostasis.

Collagen provides mechanical support to blood vessel walls and surrounding tissues. It also helps platelets recognize vascular injury. In EDS, abnormal or insufficiently supported connective tissue may allow small vessels to rupture more easily and blood to spread into surrounding tissue, producing bruises or hematomas after relatively minor force.

This can occur even when routine bloodwork is unrevealing. A platelet count measures how many platelets are present, not necessarily how effectively they activate, adhere, spread, or aggregate. Likewise, normal routine coagulation studies do not exclude every mild bleeding or platelet-function disorder.

Previous EDS studies have identified platelet-function abnormalities despite relatively unremarkable standard coagulation testing.

This does not mean that every person with EDS has a platelet disorder. EDS includes multiple subtypes with different mechanisms and risks. Vascular EDS carries a distinct risk of arterial and organ fragility that should not be generalized to people with hEDS or HSD. Easy bruising and mucosal bleeding, however, can occur across several EDS types.

What New Research Says About Platelet Dysfunction in EDS

The 2023 Bleeding-Symptom Study

A 2023 study, “Characterization of Bleeding Symptoms in Ehlers-Danlos Syndrome”, used the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool, or ISTH-BAT, to compare 52 people with classical, classical-like, hypermobile, or vascular EDS with 52 matched healthy controls.

The difference was substantial. An abnormal bleeding score was found in 32 of 52 participants with EDS, or 62 percent, compared with none of the healthy controls. The average ISTH-BAT score was 9.1 in the EDS group and 0.1 in controls. Frequently reported problems included:

•       Easy bruising

•       Muscle hematomas

•       Heavy menstrual bleeding

•       Nosebleeds

•       Oral bleeding

•       Bleeding after tooth extraction

Seven participants with EDS, or 14 percent, reported menstrual bleeding that had been life-threatening or required surgery.

These results do not establish that 62 percent of everyone with EDS has a formally diagnosable bleeding disorder. The study involved a relatively small, selected cohort. It does show that clinically meaningful bleeding symptoms are common enough that they should be asked about systematically rather than dismissed as “just part of EDS.”

The Platelet Study That Changed the Biological Picture

A mechanistic study titled “Platelet Defects in Patients and Mice with Ehlers-Danlos Syndrome” became available online in late 2025 and was formally published in the February 2026 issue of Blood. The investigators examined blood samples from people with hypermobile, classical, classical-like, and vascular EDS and also used a mouse model of classical EDS.

Platelets from the EDS groups showed reduced activation of integrin αIIbβ3, a receptor needed for platelets to bind fibrinogen, aggregate, and form a stable platelet plug. The researchers linked this to reduced phosphorylation of talin-1, a protein involved in activating the integrin. They also identified reduced expression and signaling involving GPVI, a major platelet collagen receptor, and PAR1, a thrombin receptor. Functionally, the platelets demonstrated impaired aggregation and spreading.

In plain language, some platelets in EDS appeared less responsive to key injury signals and less efficient at building the early platelet plug. This supports the idea that bleeding in EDS may involve both the tissue surrounding the vessel and the blood’s cellular response to injury.

These findings are important, but they are not yet a universal diagnostic rule or a ready-made treatment protocol. The study does not prove that every patient with EDS needs specialized platelet testing, nor does it establish a standard platelet-directed medication for routine use. It does provide a biologically plausible reason for hematology evaluation when a patient has significant bleeding symptoms despite a normal platelet count and basic coagulation results.

Heavy Menstrual Bleeding in Hypermobile EDS

Heavy menstrual bleeding is especially important because it can affect daily function long before severe anemia appears. The 2024 paper “Heavy Menstrual Bleeding in Adolescents with Joint Hypermobility Syndrome/Hypermobile-Type Ehlers-Danlos: A Review” was a clinical review, not a new experimental trial. It emphasized that heavy menstrual bleeding is well documented in adults with hEDS, while adolescent-specific evidence and treatment guidance remain comparatively limited.

Clinically, heavy menstrual bleeding can contribute to fatigue, headaches, reduced concentration, poor exercise tolerance, missed school or work, and diminished quality of life.

The American College of Obstetricians and Gynecologists recommends that adolescents presenting with heavy menstrual bleeding be evaluated for anemia from blood loss, including assessment of serum ferritin, and be screened for a possible underlying bleeding disorder when the history is suggestive.

Ferritin matters because iron deficiency may exist even when hemoglobin remains within the laboratory reference range. In one study of 114 young patients referred for heavy menstrual bleeding, 50.9 percent had ferritin below 20 ng/mL, but fewer than half of those with iron deficiency were anemic.

Hemoglobin alone identified only 41.4 percent of the patients with low ferritin. A normal hemoglobin, in other words, should not automatically end the investigation when symptoms and menstrual history suggest ongoing iron loss.

How Bleeding Symptoms Can Affect POTS and Fatigue

For patients who also have postural orthostatic tachycardia syndrome (POTS), menstruation may coincide with greater lightheadedness or reduced orthostatic tolerance. Research has demonstrated menstrual-phase differences in hemodynamics and volume-regulating hormones in people with POTS. Heavy blood loss and iron deficiency may add another physiological stressor, although the severity and mechanism vary among individuals. It is more accurate to say that heavy periods can aggravate the overall symptom burden than to assume every POTS flare is caused by menstrual blood loss.

Physical Therapy Considerations for Patients with EDS and Bleeding Tendencies

For physical therapists, bleeding history should be considered a rehab-modifying variable, much like joint instability, dysautonomia, fatigue, pain sensitivity, or post-exertional symptom exacerbation. It should not create fear or automatically exclude treatment. It should influence dosing, monitoring, and communication.

A clinical intake should ask about unexplained or unusually large bruises, recurrent hematomas, nosebleeds, gum or oral bleeding, heavy or prolonged periods, prolonged bleeding from minor cuts, bleeding after dental procedures or surgery, postpartum hemorrhage, and any personal or family history of a diagnosed bleeding disorder. Medication and supplement review also matters, because anticoagulants, antiplatelet agents, and certain anti-inflammatory medications can increase bleeding risk.

Interventions that intentionally penetrate or heavily stress tissue may require additional judgment. Dry needling commonly causes minor bleeding or bruising even in the general population. Instrument-assisted soft-tissue work, aggressive manual therapy, high-force mobilization, and rapid eccentric-loading progression may also produce more bruising or tissue irritation in a susceptible patient.

These are not universal contraindications. Treatment should be individualized, consent should be specific, and the clinician should monitor the patient’s response rather than assuming visible bruising is harmless.

Exercise remains central to EDS and HSD rehabilitation. The Ehlers-Danlos Society’s physical therapy guidance emphasizes movement control, stabilizing-muscle strength, lower joint loads, and a “start low and go slow” progression.

When heavy bleeding or iron deficiency is present, reduced exercise tolerance may reflect a systemic limitation rather than poor motivation or simple deconditioning. Temporarily adjusting volume, rest periods, upright exercise exposure, or progression speed may allow safer and more productive rehabilitation while medical evaluation is underway.

When Should Patients with EDS See a Hematologist?

Patients with recurrent or disproportionate bleeding, such as bruising from minimal contact, prolonged bleeding after minor cuts or dental work, or menstrual bleeding that soaks through protection hourly, should raise the pattern with their primary clinician, gynecologist, or hematologist. A hematology referral is also reasonable when bleeding symptoms are significant despite normal platelet counts and normal basic coagulation testing, given that these routine tests do not capture every mild bleeding or platelet-function disorder.

Severe or uncontrolled bleeding, fainting, shortness of breath, a rapidly enlarging hematoma, or new neurological symptoms requires urgent medical assessment rather than a routine referral.

Key Takeaways for Patients and Clinicians

Bleeding symptoms in EDS and HSD should be screened, documented, and taken seriously. Current evidence supports a multifactorial explanation involving connective tissue and vessel fragility, with emerging evidence of platelet dysfunction in some patients. Heavy menstrual bleeding is not only a gynecological issue. It may contribute to iron deficiency, fatigue, orthostatic symptoms, and reduced rehabilitation capacity.

The goal is not to make people afraid of movement or treatment. The goal is to recognize bleeding risk early, coordinate care appropriately, and dose rehabilitation with both tissue tolerance and hemostatic tolerance in mind.

If you’ve dealt with easy bruising, heavy periods, or bleeding that never seemed to fit any other explanation, you are not imagining it. Talk to one of our EDS-informed specialists. The first conversation is free.

Frequently Asked Questions

Can Ehlers-Danlos syndrome cause bleeding disorders?

EDS can be associated with bleeding symptoms such as easy bruising, mucosal bleeding, and heavy menstrual bleeding. Emerging research also points to platelet-function differences in some patients. This does not mean every person with EDS has a formally diagnosable bleeding disorder, but symptoms should be screened rather than dismissed.

Why do people with EDS bruise so easily?

Collagen supports blood vessel walls and helps platelets recognize injury. In EDS, weaker connective tissue support around small vessels can allow bruising with relatively minor force, even when standard bloodwork looks normal.

Does hypermobile EDS affect platelet function?

A 2026 study in Blood found that platelets from people with hypermobile, classical, classical-like, and vascular EDS showed reduced activation of a key receptor involved in forming a stable platelet plug, along with changes in collagen and thrombin receptor signaling. This suggests platelet function may be impaired in at least some patients.

Can heavy menstrual bleeding worsen POTS symptoms?

Heavy blood loss and related iron deficiency can add to the physiological load in someone who already has POTS, potentially intensifying lightheadedness or fatigue. It is more accurate to view heavy periods as one contributing stressor rather than the sole cause of a POTS flare.

Should physical therapists modify treatment for patients with bleeding symptoms?

Yes. Bleeding history should factor into intake, dosing, and monitoring, similar to how joint instability or fatigue is considered. This does not mean avoiding treatment. It means individualizing it.

Can dry needling be performed safely in EDS?

Dry needling commonly causes minor bleeding or bruising even in the general population, and this may be more pronounced in patients with EDS. It is not a universal contraindication, but consent should be specific and the clinician should monitor the response individually.

When should someone with EDS see a hematologist?

A hematology evaluation is reasonable when bleeding symptoms are recurrent, disproportionate to the triggering event, or persist despite normal platelet counts and coagulation testing. Severe or uncontrolled bleeding requires urgent medical care rather than a routine referral.

This article is for educational purposes and does not replace individualized medical evaluation. Anyone experiencing recurrent, severe, or unexplained bleeding symptoms should be evaluated by a qualified healthcare provider.